Study of Inhaled Glucocorticosteroid Administration in Asthma Patients

Hamamatsu University

Status: Completed

Conditions: Asthma

Treatments: Drug: Budesonide,hydrofluoroalkane-beclomethasone dipropionate; Drug: Budesonide,hydrofluoroalkane-beclomethasone

Study type: Observational

Funder types: Other

Identifiers

NCT00559689

H-17-43

Hamamatsu-17-43

Details and patient eligibility

About

Once-daily inhaled glucocorticosteroids treatment can sufficiently control airway inflammation in asthma patients.

Enrollment: 24 patients

Sex: All

Ages: 20 to 80 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Receive ICS for one year or more, with no change in dose within the previous 8 weeks

Exclusion criteria

• Two or more courses of oral corticosteroid in the previous 12 months
• Admission to hospital due to asthma in the previous 6 months
• Admission to the intensive care unit due to asthma at any time in the past
• Current cigarette smoker.

Trial design

24 participants in 2 patient groups

1

Description:

receive once-daily administration of inhaled glucocorticosteroids at bedtime

Treatment:

Drug: Budesonide,hydrofluoroalkane-beclomethasone

2

Description:

receive twice-daily administration of inhaled glucocorticosteroids

Treatment:

Drug: Budesonide,hydrofluoroalkane-beclomethasone dipropionate